We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.71B
1-Year Est. Return
65.19%
This Fund
S&P 500
This Quarter
Est. Return
+12.3%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$1.91B
AUM Growth
+$117M
(+6.5%)
Cap. Flow
-$7.1M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
29.56%
Holding
333
New
49
Increased
56
Reduced
52
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$38.3M |
| 2 |
DexCom
DXCM
|
+$29M |
| 3 |
SLB Ltd
SLB
|
+$26.9M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
+$23.4M |
| 5 |
iShares Russell 2000 Value ETF
IWN
|
+$19.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$44.6M |
| 2 |
Microsoft
MSFT
|
+$25.4M |
| 3 |
Nike
NKE
|
+$22.2M |
| 4 |
Edwards Lifesciences
EW
|
+$18.5M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.56% |
| 2 | Healthcare | 16.67% |
| 3 | Consumer Discretionary | 14.24% |
| 4 | Financials | 13.38% |
| 5 | Miscellaneous | 10.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
PRA Group
PRAA
$726M
| $38.8K | ﹤0.01% |
1,150
| – | – |
|
277
Medtronic
MDT
$120B
| $37.3K | ﹤0.01% |
480
| – | – |
|
|
SEE
278
DELISTED
Sealed Air
SEE
| $35.9K | ﹤0.01% |
720
| – | – |
|
279
F5
FFIV
$24.4B
| $20.1K | ﹤0.01% |
140
| – | – |
|
280
Under Armour
UAA
$2.13B
| $13.6K | ﹤0.01% |
1,340
| – | – |
|
281
Under Armour Class C
UA
$2.07B
| $12K | ﹤0.01% |
1,349
| – | – |
|
282
Workhorse Group
WKHS
$33.3M
| $11.5K | ﹤0.01% |
3
| – | – |
|
283
Agree Realty
ADC
$8.72B
| – | – |
-67,570
| Closed | -$4.57M |
|
|
APLS
284
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-57,890
| Closed | -$3.95M |
|
285
Arvinas
ARVN
$540M
| – | – |
-42,890
| Closed | -$1.91M |
|
|
EFOR
286
Everforth Inc
EFOR
$1.39B
| – | – |
-60,175
| Closed | -$5.44M |
|
287
BridgeBio Pharma
BBIO
$13.4B
| – | – |
-90,470
| Closed | -$899K |
|
288
Americold
COLD
$4.28B
| – | – |
-130,960
| Closed | -$3.22M |
|
|
CTRA
289
DELISTED
Coterra Energy
CTRA
| – | – |
-72,740
| Closed | -$1.9M |
|
290
CryoPort
CYRX
$826M
| – | – |
-65,310
| Closed | -$1.59M |
|
291
Caesars Entertainment
CZR
$6.04B
| – | – |
-127,860
| Closed | -$4.13M |
|
292
Walt Disney
DIS
$184B
| – | – |
-811
| Closed | -$77K |
|
293
Denali Therapeutics
DNLI
$3.26B
| – | – |
-127,460
| Closed | -$3.91M |
|
294
Entegris
ENTG
$19.8B
| – | – |
-8,585
| Closed | -$713K |
|
295
FTI Consulting
FCN
$4.06B
| – | – |
-40,520
| Closed | -$6.71M |
|
296
FIVE9
FIVN
$2.47B
| – | – |
-61,854
| Closed | -$4.64M |
|
297
Glaukos
GKOS
$10.1B
| – | – |
-54,150
| Closed | -$2.88M |
|
298
Grocery Outlet
GO
$1.14B
| – | – |
-155,540
| Closed | -$5.18M |
|
299
Green Plains
GPRE
$1.04B
| – | – |
-144,368
| Closed | -$4.2M |
|
|
GTLS
300
DELISTED
Chart Industries
GTLS
| – | – |
-39,945
| Closed | -$7.36M |
|
Similar funds
MSC
BC
FEG
HCM
OH
BCM
CCI
MCM
Castleark Management's Q4 2022 Portfolio in Review
As of Q4 2022, Castleark Management held 333 positions worth $1.91B, up 6.5% from $1.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Castleark Management's Q4 2022 filing shows 49 new, 56 increased, 52 reduced and 51 closed positions. Its largest new stake was iShares MSCI Japan ETF: 445,300 shares worth $24.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $44.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Castleark Management's largest Q4 2022 buy was iShares MSCI Japan ETF: 445,300 shares worth $24.2M.
- Castleark Management added most to iShares MSCI Emerging Markets ETF in Q4 2022, an estimated $38.3M increase.
- Castleark Management's biggest Q4 2022 reduction was Microsoft, cutting an estimated $25.4M.
- Castleark Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2022, selling an estimated $44.6M.
- Castleark Management's ten largest holdings make up 30% of its $1.91B portfolio in Q4 2022.
- Castleark Management opened 49 new positions and closed 51 in Q4 2022.
- Castleark Management's portfolio value rose 6.5% quarter-over-quarter to $1.91B.
Based on Castleark Management's 13F filing for Q4 2022, filed 10 Feb 2023.